Philipp Baumann

542 total citations
17 papers, 436 citations indexed

About

Philipp Baumann is a scholar working on Psychiatry and Mental health, Hematology and Philosophy. According to data from OpenAlex, Philipp Baumann has authored 17 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 6 papers in Hematology and 6 papers in Philosophy. Recurrent topics in Philipp Baumann's work include Schizophrenia research and treatment (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Mental Health and Psychiatry (6 papers). Philipp Baumann is often cited by papers focused on Schizophrenia research and treatment (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Mental Health and Psychiatry (6 papers). Philipp Baumann collaborates with scholars based in Switzerland, Germany and United Kingdom. Philipp Baumann's co-authors include Ralf Schmidmaier, Sonja Mandl–Weber, Fuat Oduncu, Bertold Emmerich, Christian Adam, Irmgard Bumeder, Philippe Conus, Luis Alameda, Philippe Golay and Gerold Meinhardt and has published in prestigious journals such as Blood, Experimental Cell Research and Psychiatry Research.

In The Last Decade

Philipp Baumann

16 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philipp Baumann Switzerland 9 243 113 98 68 63 17 436
Ilaria Rocco Italy 13 226 0.9× 137 1.2× 96 1.0× 53 0.8× 32 0.5× 35 526
Marta Morawska Poland 12 120 0.5× 115 1.0× 133 1.4× 38 0.6× 69 1.1× 37 418
Amy Saur Conway United States 8 278 1.1× 155 1.4× 85 0.9× 17 0.3× 44 0.7× 12 449
Ana Isabel Enríquez Rodríguez Spain 9 119 0.5× 105 0.9× 30 0.3× 27 0.4× 18 0.3× 27 430
Julie Rowe United States 11 135 0.6× 181 1.6× 71 0.7× 16 0.2× 21 0.3× 30 495
Colin D. Godwin United States 8 336 1.4× 162 1.4× 306 3.1× 76 1.1× 15 0.2× 22 719
En Xu China 15 251 1.0× 136 1.2× 35 0.4× 17 0.3× 35 0.6× 22 629
Joi Dunbar United States 11 314 1.3× 100 0.9× 24 0.2× 19 0.3× 98 1.6× 23 590
Stephen L. Rose United States 20 530 2.2× 364 3.2× 37 0.4× 18 0.3× 62 1.0× 33 1.1k
Noam Asna Israel 10 196 0.8× 144 1.3× 18 0.2× 11 0.2× 53 0.8× 31 557

Countries citing papers authored by Philipp Baumann

Since Specialization
Citations

This map shows the geographic impact of Philipp Baumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Baumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Baumann more than expected).

Fields of papers citing papers by Philipp Baumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Baumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Baumann. The network helps show where Philipp Baumann may publish in the future.

Co-authorship network of co-authors of Philipp Baumann

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Baumann. A scholar is included among the top collaborators of Philipp Baumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Baumann. Philipp Baumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Golay, Philippe, et al.. (2019). Moderating role of cannabis use between insight and depression in early psychosis. Schizophrenia Research. 215. 61–65. 7 indexed citations
2.
Conus, Philippe, et al.. (2019). City Avoidance in the Early Phase of Psychosis: A Neglected Domain of Assessment and a Potential Target for Recovery Strategies. Frontiers in Psychiatry. 10. 342–342. 5 indexed citations
3.
Golay, Philippe, Philipp Baumann, Raoul Jenni, Kim Q., & Philippe Conus. (2018). Patients participating to neurobiological research in early psychosis: A selected subgroup?. Schizophrenia Research. 201. 249–253. 4 indexed citations
4.
5.
Stellbrink, Christoph, et al.. (2018). Transvenöse Neurostimulation bei herzinsuffizienzassoziierter zentraler Schlafapnoe. Herzschrittmachertherapie + Elektrophysiologie. 29(4). 377–382. 1 indexed citations
6.
Alameda, Luis, Philippe Golay, Philipp Baumann, et al.. (2017). Qui a besoin de suivi intensif dans le milieu dans un programme spécialisé pour les psychoses émergentes ?. Annales Médico-psychologiques revue psychiatrique. 176(1). 74–79.
7.
Baumann, Philipp, et al.. (2017). Formulation de cas dans la psychose débutante : Quels outils pour le travail en équipe?. The Canadian Journal of Psychiatry. 62(7). 457–464. 3 indexed citations
8.
Moulin, Valérie, Luis Alameda, M.M. Gholamrezaee, et al.. (2017). Insight et comportements violents dans une cohorte de patients souffrant de premiers épisodes de psychose. The Canadian Journal of Psychiatry. 63(1). 20–29. 6 indexed citations
9.
Alameda, Luis, Philippe Golay, Philipp Baumann, et al.. (2016). Assertive outreach for “difficult to engage” patients: A useful tool for a subgroup of patients in specialized early psychosis intervention programs. Psychiatry Research. 239. 212–219. 19 indexed citations
10.
Baumann, Philipp, et al.. (2013). Les premiers épisodes psychotiques : de l’importance du case management. L Évolution Psychiatrique. 78(1). 41–51. 10 indexed citations
11.
Baumann, Philipp, et al.. (2011). Simultaneous targeting of PI3K and mTOR with NVP-BGT226 is highly effective in multiple myeloma. Anti-Cancer Drugs. 23(1). 131–138. 44 indexed citations
12.
Baumann, Philipp, Sonja Mandl–Weber, Christian Adam, et al.. (2009). Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells. Molecular Cancer Therapeutics. 8(2). 366–375. 95 indexed citations
13.
Baumann, Philipp, Sonja Mandl–Weber, Fuat Oduncu, & Ralf Schmidmaier. (2008). Alkylating agents induce activation of NFκB in multiple myeloma cells. Leukemia Research. 32(7). 1144–1147. 23 indexed citations
14.
Baumann, Philipp, Sonja Mandl–Weber, Fuat Oduncu, & Ralf Schmidmaier. (2008). The novel orally bioavailable inhibitor of phosphoinositol-3-kinase and mammalian target of rapamycin, NVP-BEZ235, inhibits growth and proliferation in multiple myeloma. Experimental Cell Research. 315(3). 485–497. 101 indexed citations
15.
Meinel, Felix G., Sonja Mandl–Weber, Philipp Baumann, Johann Leban, & Ralf Schmidmaier. (2008). The Novel NFkB Inhibitor V1810 Induces Apoptosis and Cell Cycle Arrest in Multiple Myeloma Cells and Overcomes NFkB Mediated Drug Resistance.. Blood. 112(11). 1715–1715. 3 indexed citations
16.
Mandl–Weber, Sonja, et al.. (2007). Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways. Journal of Cancer Research and Clinical Oncology. 134(2). 245–253. 56 indexed citations
17.
Schmidmaier, Ralf, et al.. (2006). Synergistic antimyeloma effects of zoledronate and simvastatin. Anti-Cancer Drugs. 17(6). 621–629. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilaria Rocco Breakdown of academic impact, for papers by Marta Morawska Breakdown of academic impact, for papers by Amy Saur Conway Breakdown of academic impact, for papers by Ana Isabel Enríquez Rodríguez Breakdown of academic impact, for papers by Julie Rowe Breakdown of academic impact, for papers by Colin D. Godwin Breakdown of academic impact, for papers by En Xu Breakdown of academic impact, for papers by Joi Dunbar Breakdown of academic impact, for papers by Stephen L. Rose Breakdown of academic impact, for papers by Noam Asna
Rankless by CCL
2026